| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Johnson & Johnson | 5 | Q2 2020 | 3.4% |
| Microsoft Corporation | 5 | Q2 2020 | 3.2% |
| Merck & Co. Inc. | 5 | Q2 2020 | 3.2% |
| SPDR S&P 500 ETF Trust Series | 5 | Q2 2020 | 2.5% |
| Citigroup Inc. | 5 | Q2 2020 | 2.6% |
| AbbVie Inc. | 5 | Q2 2020 | 2.3% |
| JPMorgan Chase & Co | 5 | Q2 2020 | 2.3% |
| Citizens Financial Group | 5 | Q2 2020 | 2.3% |
| Avery Dennison Corp. | 5 | Q2 2020 | 2.2% |
| Bristol-Myers Squibb Co. | 5 | Q2 2020 | 2.3% |
View TRADITION ASSET MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-08-06 |
| 13F-HR | 2020-05-05 |
| 13F-HR | 2020-02-05 |
| 13F-HR | 2019-10-30 |
| 13F-HR | 2019-08-06 |
View TRADITION ASSET MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.